What can we help you find?

Leading the way in transplantation

Filter results for:

New Job Alert: 3-years Postdoctoral position in Transplant Immunology

3-years Postdoctoral position in Transplant Immunology at the Vall d’Hebron Institute of Research (VHIR), in the Translational Nephrology and Transplantation Laboratory group leaded by professor Oriol Bestard, in Barcelona. Learn more: VHIR-PostDoc position_Dr OriolBestard How to apply: Applicants should submit a full Curriculum Vitae and a cover letter with the reference “post-doctoral position at the…

Read more

WEBINAR: What you need to know about vaccinating your kidney transplanted patients against COVID-19

This educational webinar will discuss the efficacy of current COVID-19 vaccine strategies for transplanted patients. The first talk will focus on the experience with heterologous vaccinations and the pro´s and con´s for vector vaccines in transplant patients. The second talk summarises previous studies on second and third booster (homogenous and heterologous) vaccinations – and gives…

Read more

Management of the patient with HLA antibodies: join the discussion

Recommendations from Workstream 6 of the ESOT Transplantation Learning Journey (TLJ 2.0) project, concerning the management of the patient with HLA antibodies We are pleased to present the recommendations from Workstream 6 of the ESOT Transplantation Learning Journey (TLJ 2.0) project, concerning the management of the patient with HLA antibodies. Over recent months, our group…

Read more

ESOT multi-organ registry

On March 5th 2021, ESOT opened a tender for a technical provider that will build the multi-organ registry. ESOT is seeking the support of additional European national authorities and expect to finalise agreement with participating countries by the end of April 2021. In addition, ESOT is establishing contacts with non-European countries and registries. read more…

Read more

The COVID-19 Vaccine Studies

Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader…

Read more